Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Zevra Therapeutics (ZVRA)
- 13.330
- +0.360+2.78%
Trading Jun 12 10:03 ET
788.00MMarket Cap6.63P/E (TTM)
13.330High12.950Low116.02KVolume12.980Open12.970Prev Close1.52MTurnover0.21%Turnover Ratio9.87P/E (Static)59.12MShares14.27052wk High3.83P/B732.59MFloat Cap7.16052wk Low--Dividend TTM54.96MShs Float418.400Historical High--Div Yield TTM2.93%Range %2.560Historical Low13.098Avg Price1Lot Size
Zevra Therapeutics (ZVRA) Key Financial Indicators
ZVRA Earnings per Share (EPS)
According to the latest financial report of Zevra Therapeutics, the latest earnings per share (TTM) for the company is 0.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ZVRA Free Cash Flow (FCF)
Interested in knowing about Zevra Therapeutics's free cash flow? The latest report shows it as 6.11M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ZVRA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zevra Therapeutics shows that the company's current ratio is 4.89, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ZVRA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zevra Therapeutics, the quick ratio is 4.74, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ZVRA Return on Equity (ROE)
Want to learn more about the financial health of Zevra Therapeutics? The latest ROE figure is 21.02%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ZVRA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zevra Therapeutics, the total asset return on investment (ROA) is 13.45%.
Currency: USD
Quarterly
Loading...
ZVRA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zevra Therapeutics's latest financial report to see how their gross margin is doing - currently at 94.76%.
Currency: USD
Quarterly
Loading...
ZVRA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zevra Therapeutics, the net profit margin is 104.61%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm